Loading the section
The price of Celularity Inc. (CELU) on October 9, 2026 is 1.54 USD, +5.82% on the day. Over 52 weeks the stock traded between 0.5600 USD and 2.55 USD; the price now sits 45% of the way up that range. Over the past year the price changed by -28.43%. Market capitalization is 42.10 million USD, rank 261 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Celularity Inc. trades on Nasdaq under the ticker CELU. The company belongs to the Health care sector. The trading history on this page starts on 08 August 2019.
Over the past 52 weeks CELU has traded between 0.5600 $ and 2.55 $. As of 09 October 2026 the price stood 50.25 % of the way from the 52-week low to the high.
Over one year CELU shares fell 27.44 %; over six months they rose 22.83 %. Volatility over 90 days is 184.72 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss for the latest fiscal year, so a price-to-earnings ratio is not calculated. Price to sales is 1.7, below the sector median of 4.0. Calculated from reports for the period ending 31 December 2025.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 1.46 | 1.57 | 1.45 | 1.56 | 53,200 |
| 08 October 2026 | 1.46 | 1.50 | 1.43 | 1.46 | 103,700 |
| 07 October 2026 | 1.53 | 1.57 | 1.47 | 1.47 | 68,900 |
| 06 October 2026 | 1.70 | 1.77 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:170 PARK AVE, FLORHAM PARK, NJ, 07932, US
Celularity Inc. reported revenue of 27M $ and a net loss of 92M $ for the latest fiscal year. Net margin is −345.45 %. Revenue changed by −51.03 % year over year. Earnings per share are −3.59 $. Market capitalisation is 45M $.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.54 |
| 1.58 |
| 260,900 |
| 05 October 2026 | 1.60 | 1.80 | 1.57 | 1.71 | 282,000 |
| 02 October 2026 | 1.37 | 1.64 | 1.36 | 1.60 | 220,500 |
| 01 October 2026 | 1.34 | 1.38 | 1.30 | 1.38 | 141,800 |
| 30 September 2026 | 1.37 | 1.37 | 1.28 | 1.35 | 54,500 |
| 29 September 2026 | 1.38 | 1.40 | 1.33 | 1.37 | 39,500 |
| 28 September 2026 | 1.40 | 1.46 | 1.35 | 1.40 | 112,200 |
| 25 September 2026 | 1.33 | 1.41 | 1.32 | 1.38 | 164,900 |
| 24 September 2026 | 1.17 | 1.35 | 1.17 | 1.32 | 449,400 |
| 23 September 2026 | 1.17 | 1.18 | 1.13 | 1.15 | 76,700 |
| 22 September 2026 | 1.22 | 1.26 | 1.16 | 1.18 | 154,700 |
| 21 September 2026 | 1.27 | 1.33 | 1.24 | 1.24 | 214,000 |
| 18 September 2026 | 1.28 | 1.35 | 1.22 | 1.31 | 188,200 |
| 17 September 2026 | 1.29 | 1.38 | 1.27 | 1.27 | 77,700 |
| 16 September 2026 | 1.26 | 1.39 | 1.21 | 1.29 | 180,900 |
| 15 September 2026 | 1.33 | 1.40 | 1.24 | 1.24 | 148,600 |
| 14 September 2026 | 1.32 | 1.43 | 1.31 | 1.40 | 205,400 |